Welcome to the NEOMED Clozapine Assistance Service

training and resources for medical professionals who care for people with schizophrenia

Phone: 330.325.6848 Email: clozapine@neomed.edu

Before I started taking clozapine, I had racing thoughts and acute psychosis. I was tormented 24 hours a day and could get no relief. Within weeks of starting clozapine, I began to feel a kind of tranquility starting to set in. After five months of gradually increasing the dosage, my psychotic symptoms began to subside. After two years, I was discharged from the hospital with medical consent. The year was 1991, and I have been a functioning member of society since then. I have a college degree and a paralegal certificate, and I have been employed full time for four years. – Kirk

Clozapine restores lives for people with schizophrenia in ways that other medications just can’t. People report that clozapine makes it possible for them to leave the hospital, live independently, obtain employment and socialize more easily. Eighty-one percent of those surveyed said that clozapine was better or much better than their previous treatments. (Source: Taylor et al., 2000).

Listen to Bethany’s story of how clozapine restored her life

Clozapine is the best medication for about 20 percent of people with schizophrenia, yet in the United States it is used with just 4 percent of the intended patient population. Sixteen percent of the people with schizophrenia – almost half a million individuals – are denied the quality of life that can be realized with this unique medication.

There are multiple types of schizophrenia, each with a similar outward appearance, but with different underlying pathophysiology. Almost every medication approved for the treatment of schizophrenia works by blocking a very specific subtype of receptor for the neurotransmitter dopamine. Dopamine-receptor blocking medications are very effective for about two-thirds of patients with schizophrenia. However, for the one-third of the population that has a schizophrenia that has little to do with dopamine over-activity, dopamine-blocking medications are not helpful. Clozapine succeeds where other medications fail because it works on other factors that contribute to persistent psychosis. The next Virtual Clozapine REMS training will be July 18 from 6 – 8 p.m. Register at https://freeclozapinetraining.eventbrite.com

Through training to prepare clinicians to pass the clozapine knowledge exam required to enroll in the Clozapine REMS, the Clozapine Assistance Line, frequently asked questions and resources, the Northeast Ohio Medical University (NEOMED) Clozapine Assistance Service motivates, trains, coaches and supports licensed prescribing clinicians, or individuals about to acquire such licensure, to learn about clozapine and to prescribe it to patients who are likely to benefit from this medication.